2024
Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.c.7075692.v1DOI: 10.1158/0008-5472.c.7075692.v1
Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.c.7075692DOI: 10.1158/0008-5472.c.7075692
Mielgo Iza, A. (n.d.). Mesothelin secretion by pancreatic cancer cells co-opts macrophages and promotes metastasis. Cancer Research. doi:10.1158/0008-5472.CAN-23-1542DOI: 10.1158/0008-5472.CAN-23-1542
Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224576DOI: 10.1158/0008-5472.25224576
Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Data from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224576.v1DOI: 10.1158/0008-5472.25224576.v1
Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224573DOI: 10.1158/0008-5472.25224573
Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figure legends from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224573.v1DOI: 10.1158/0008-5472.25224573.v1
Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224567DOI: 10.1158/0008-5472.25224567
Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Figures from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224567.v1DOI: 10.1158/0008-5472.25224567.v1
Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224564DOI: 10.1158/0008-5472.25224564
Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis (Other)
Luckett, T., Abudula, M., Ireland, L., Glenn, M., Bellomo, G., Stafferton, R., . . . Mielgo, A. (2024). Supplementary Tables from Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. doi:10.1158/0008-5472.25224564.v1DOI: 10.1158/0008-5472.25224564.v1
2023
CREATION OF ISOGENIC CELL LINE MODELS OF 17P DELETION TO STUDY CLONAL EVOLUTION AND MECHANISMS OF THERAPY RESISTANCE IN CLL AND DLBCL (Journal article)
van Kampen, F. L., Glenn, M., Pettitt, A., Kalakonda, N., & Slupsky, J. (2023). CREATION OF ISOGENIC CELL LINE MODELS OF 17P DELETION TO STUDY CLONAL EVOLUTION AND MECHANISMS OF THERAPY RESISTANCE IN CLL AND DLBCL. Hematological Oncology, 41(S2), 798-799. doi:10.1002/hon.3165_647DOI: 10.1002/hon.3165_647
2020
Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer (Journal article)
Clifford, R. E., Govindarajah, N., Bowden, D., Sutton, P., Glenn, M., Darvish-Damavandi, M., . . . Vimalachandran, D. (2020). Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer. Cells, 9(12). doi:10.3390/cells9122693DOI: 10.3390/cells9122693
2019
Austin, J. A., Jenkins, R. E., Austin, G. M., Glenn, M. A., Dunn, K., Scott, L., . . . Clark, R. E. (2019). Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells. BIOCHEMICAL JOURNAL, 476, 2255-2269. doi:10.1042/BCJ20190121DOI: 10.1042/BCJ20190121
CIP2A alters energy metabolism in CML cells, thus contributing to TKI resistance (Conference Paper)
Austin, J. A., Austin, G., Glenn, M., Dunn, K., Scott, L., Lucas, C., & Clark, R. (2019). CIP2A alters energy metabolism in CML cells, thus contributing to TKI resistance. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 185 (pp. 54). Retrieved from https://www.webofscience.com/
2018
In chronic myeloid leukaemia cells, the oncoprotein CIP2A binds directly to and alters expression of many cellular proteins, independent of effects on protein phosphatase 2A (PP2A) (Conference Paper)
Austin, J. A., Lucas, C. M., Jenkins, R. E., Dunn, K., Scott, L. J., Glenn, M. A., . . . Clark, R. E. (2018). In chronic myeloid leukaemia cells, the oncoprotein CIP2A binds directly to and alters expression of many cellular proteins, independent of effects on protein phosphatase 2A (PP2A). In BRITISH JOURNAL OF HAEMATOLOGY Vol. 181 (pp. 52-53). Retrieved from https://www.webofscience.com/
2017
Al-Sanabra, O., Duckworth, A. D., Glenn, M. A., Brown, B. R., Angelillo, P., Lee, K., . . . Slupsky, J. R. (2017). Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells. Scientific Reports, 7. doi:10.1038/srep43228DOI: 10.1038/srep43228
2016
Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain (Journal article)
Iyer, D., Vartak, S. V., Mishra, A., Goldsmith, G., Kumar, S., Srivastava, M., . . . Raghavan, S. C. (2016). Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain. The Federation of European Biochemical Societies (FEBS) Journal, 283(18), 3408-3437. doi:10.1111/febs.13815DOI: 10.1111/febs.13815
2014
CC-122 Has Robust Anti-Proliferative Activity in a Primary Chronic Lymphocytic Leukemia (CLL) Co-Culture Model and Is Superior to Lenalidomide (Journal article)
Blocksidge, J., Glenn, M., Gandhi, A. K., Klippel, A., Pourdehnad, M., Chopra, R., & Kalakonda, N. (2014). CC-122 Has Robust Anti-Proliferative Activity in a Primary Chronic Lymphocytic Leukemia (CLL) Co-Culture Model and Is Superior to Lenalidomide. BLOOD, 124(21). doi:10.1182/blood.V124.21.4682.4682DOI: 10.1182/blood.V124.21.4682.4682
Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy. (Journal article)
Duckworth, A., Glenn, M., Slupsky, J. R., Packham, G., & Kalakonda, N. (2014). Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy.. Blood, 123(21), 3277-3285. doi:10.1182/blood-2013-11-539049DOI: 10.1182/blood-2013-11-539049
2013
Differential induction of PRDM1 in chronic lymphocytic leukaemia (Conference Paper)
Duckworth, A. D., Glenn, M. A., Venkateswarlu, P., Slupsky, J. R., Cawley, J. C., & Kalakonda, N. (2013). Differential induction of PRDM1 in chronic lymphocytic leukaemia. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 161 (pp. 45). Retrieved from https://www.webofscience.com/
Physical and functional characterisation of tumour-derived exosomes from chronic lymphocytic leukemia (CLL) patient samples (Conference Paper)
Farahai, M., Rubbi, C., Bee, A., Glenn, M., Blocksidge, J., & Kalakonda, N. (2013). Physical and functional characterisation of tumour-derived exosomes from chronic lymphocytic leukemia (CLL) patient samples. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 161 (pp. 45-46). Retrieved from https://www.webofscience.com/
Protein kinase C bII expression is regulated by Sp1 in chronic lymphocytic leukaemia cells (Conference Paper)
Al-Sanabra, O., Glenn, M., Kalakonda, N., & Slupsky, J. (2013). Protein kinase C bII expression is regulated by Sp1 in chronic lymphocytic leukaemia cells. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 161 (pp. 42-43). Retrieved from https://www.webofscience.com/
Regulation of integrin α4 expression in CLL cells (Conference Paper)
Glenn, M., Duckworth, A., Blocksidge, J., Bee, A., Slupsky, J., & Kalakonda, N. (2013). Regulation of integrin α4 expression in CLL cells. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 161 (pp. 43). Retrieved from https://www.webofscience.com/
2011
Insights Into the Differential Induction of PRDM1 in CLL Cells: Relevance for Pathobiology and Disease Therapeutics (Conference Paper)
Duckworth, A., Glenn, M., Cawley, J. C., & Kalakonda, N. (2011). Insights Into the Differential Induction of PRDM1 in CLL Cells: Relevance for Pathobiology and Disease Therapeutics. In BLOOD Vol. 118 (pp. 769). Retrieved from https://www.webofscience.com/
2010
Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition (Journal article)
Zhuang, J., Hawkins, S. F., Glenn, M. A., Lin, K., Johnson, G. G., Carter, A., . . . Pettitt, A. R. (2010). Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95(1), 110-118. doi:10.3324/haematol.2009.010272DOI: 10.3324/haematol.2009.010272
Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition (Journal article)
Zhuang, J., Hawkins, S. F., Glenn, M. A., Lin, K., Johnson, G. G., Carter, A., . . . Pettitt, A. R. (2010). Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95(1), 110-118. doi:10.3324/haematol.2009.010272DOI: 10.3324/haematol.2009.010272
Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. (Journal article)
Zhuang, J., Hawkins, S. F., Glenn, M. A., Lin, K., Johnson, G. G., Carter, A., . . . Pettitt, A. R. (2010). Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition.. Haematologica, 95(1), 110-118.
2006
c-Abl expression in chronic lymphocytic leukemia cells: Clinical and therapeutic implications (Journal article)
Lin, K., Glenn, M. A., Harris, R. J., Duckworth, A. D., Dennett, S., Cawley, J. C., . . . Slupsky, J. R. (2006). c-Abl expression in chronic lymphocytic leukemia cells: Clinical and therapeutic implications. CANCER RESEARCH, 66(15), 7801-7809. doi:10.1158/0008-5472.CAN-05-3901DOI: 10.1158/0008-5472.CAN-05-3901
2004
The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia (Journal article)
Kamiguti, A. S., Lee, E. S., Till, K. J., Harris, R. J., Glenn, M. A., Lin, K., . . . Cawley, J. C. (2004). The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 125(2), 128-140. doi:10.1111/j.1365-2141.2004.04877.xDOI: 10.1111/j.1365-2141.2004.04877.x
2003
Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein (Journal article)
Brinkmann, M. M., Glenn, M., Rainbow, L., Kieser, A., Henke-Gendo, C., & Schulz, T. F. (2003). Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. JOURNAL OF VIROLOGY, 77(17), 9346-9358. doi:10.1128/JVI.77.17.9346-9358.2003DOI: 10.1128/JVI.77.17.9346-9358.2003
2002
Response of hairy cells to IFN-α involves induction of apoptosis through autocrine TNF-α and protection by adhesion (Journal article)
Baker, P. K., Pettitt, A. R., Slupsky, J. R., Chen, H. J., Glenn, M. A., Zuzel, M., & Cawley, J. C. (2002). Response of hairy cells to IFN-α involves induction of apoptosis through autocrine TNF-α and protection by adhesion. BLOOD, 100(2), 647-653. doi:10.1182/blood.V100.2.647DOI: 10.1182/blood.V100.2.647
DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein (Journal article)
Sommerville, L. M., Radford, A. D., Glenn, M., Dawson, S., Gaskell, C. J., Kelly, D. F., . . . Gaskell, R. M. (2002). DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein. VACCINE, 20(13-14), 1787-1796. doi:10.1016/S0264-410X(02)00024-5DOI: 10.1016/S0264-410X(02)00024-5
Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion (Journal article)
Baker, P. K., Pettitt, A. R., Slupsky, J. R., Chen, H. J., Glenn, M. A., Zuzel, M., & Cawley, J. C. (2002). Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion. Blood, 100(2), 647-653.
Response of hairy cells to α-IFN involves induction of apoptosis through autocrine TNF-α and protection by adhesion. (Conference Paper)
Baker, P. K., Pettitt, A. R., Slupsky, J. R., Chen, H. J., Glenn, M. A., Zuzel, M., & Cawley, J. C. (2002). Response of hairy cells to α-IFN involves induction of apoptosis through autocrine TNF-α and protection by adhesion.. In BLOOD Vol. 100 (pp. 596A). Retrieved from https://www.webofscience.com/
1999
The human herpesvirus-8 ORF 57 gene and its properties. (Journal article)
Bello, L. J., Davison, A. J., Glenn, M. A., Whitehouse, A., Rethmeier, N., Schulz, T. F., & Barklie Clements, J. (1999). The human herpesvirus-8 ORF 57 gene and its properties.. The Journal of general virology, 80 ( Pt 12), 3207-3215. doi:10.1099/0022-1317-80-12-3207DOI: 10.1099/0022-1317-80-12-3207
Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and persistently infected cats (Journal article)
Radford, A. D., Bennett, M., McArdle, F., Dawson, S., Turner, P. C., Williams, R. A., . . . Gaskell, R. M. (1999). Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and persistently infected cats. VETERINARY MICROBIOLOGY, 69(1-2), 67-68. doi:10.1016/S0378-1135(99)00090-5DOI: 10.1016/S0378-1135(99)00090-5
Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs (Journal article)
Glenn, M., Radford, A. D., Turner, P. C., Carter, M., Lowery, D., DeSilver, D. A., . . . Gaskell, R. M. (1999). Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs. VETERINARY MICROBIOLOGY, 67(3), 175-193. doi:10.1016/S0378-1135(99)00043-7DOI: 10.1016/S0378-1135(99)00043-7
Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus (Journal article)
Glenn, M., Rainbow, L., Auradé, F., Davison, A., & Schulz, T. F. (1999). Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. JOURNAL OF VIROLOGY, 73(8), 6953-6963. doi:10.1128/JVI.73.8.6953-6963.1999DOI: 10.1128/JVI.73.8.6953-6963.1999
1998
Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats (Journal article)
Radford, A. D., Turner, P. C., Bennett, M., McArdle, F., Dawson, S., Glenn, M. A., . . . Gaskell, R. M. (1998). Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats. JOURNAL OF GENERAL VIROLOGY, 79, 1-10. Retrieved from https://www.webofscience.com/
1997
The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures (Journal article)
Radford, A. D., Bennett, M., McArdle, F., Dawson, S., Turner, P. C., Glenn, M. A., & Gaskell, R. M. (1997). The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. VACCINE, 15(12-13), 1451-1458. doi:10.1016/S0264-410X(97)00059-5DOI: 10.1016/S0264-410X(97)00059-5
1996
Sequence analysis of the capsid gene of feline calcivirus strain F65. (Journal article)
Glenn, M. A., Gaskell, R. M., & Turner, P. C. (1996). Sequence analysis of the capsid gene of feline calcivirus strain F65.. BIOCHEMICAL SOCIETY TRANSACTIONS, 24(3), S414. doi:10.1042/bst024414sDOI: 10.1042/bst024414s